Healthcare stocks were softer late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.2%
The iShares Biotechnology ETF (IBB) fell 1.1%.
In corporate news, Eli Lilly (LLY) said Friday that the US Food and Drug Administration has approved Inluriyo in combination with Verzenio for breast cancer. Lilly shares were fractionally higher.